• SN-38 Disrupts FUBP1–FUSE Binding: New Mechanisms in Cancer

  2026-06-28

  This study reveals that 7-Ethyl-10-hydroxycamptothecin (SN-38), beyond inhibiting DNA topoisomerase I, also blocks the FUBP1 oncoprotein from binding to its DNA target, FUSE. These dual actions illuminate new opportunities for apoptosis induction and cell cycle arrest in advanced cancer research, particularly in hepatocellular and colon carcinoma models.

• VX-702: Selective p38α MAPK Inhibitor for Inflammation Resea

  2026-06-27

  VX-702 is a potent, ATP-competitive p38α MAPK inhibitor that enables precise cytokine modulation in preclinical models. Its high selectivity provides robust suppression of pro-inflammatory cytokines and offers translational utility in arthritis and cardiac injury research.

• GLP-1 (9-36) amide: Precision Tool for GLP-1R Signaling Rese

  2026-06-26

  GLP-1 (9-36) amide enables high-specificity dissection of GLP-1 receptor signaling, offering unique advantages for metabolic and type 2 diabetes research. This guide translates cutting-edge assay insights and troubleshooting strategies into actionable workflows, maximizing reproducibility and data integrity for advanced GPCR pathway studies.

• Applied Insights with ZCL278: Selective Cdc42 Inhibitor Work

  2026-06-26

  ZCL278 empowers researchers to precisely dissect the Cdc42 signaling pathway, enabling robust cell motility suppression and neuronal branching inhibition in advanced models. This guide delivers workflow enhancements, protocol parameters, and troubleshooting tips, translating the latest reference breakthroughs into actionable strategies for cell and neurobiology labs.

• Palmitic acid (Hexadecanoic Acid): Technical Handling for Re

  2026-06-25

  Palmitic acid (SKU N2456) supplies researchers with a 98% purity, well-characterized saturated long-chain fatty acid for reproducible studies targeting lipid metabolism, protein palmitoylation, and metabolic disorder pathways. It is not suitable for protocols requiring aqueous solubility or long-term solution storage. Correct solvent selection and prompt use are essential for assay reliability.

• Reliable Glucose Uptake Measurement with 2-NBDG Glucose Upta

  2026-06-25

  This article addresses pivotal workflow challenges in glucose metabolism research and demonstrates how the 2-NBDG Glucose Uptake Assay Kit (SKU K2212) enables reproducible, non-radioactive, and single-cell level quantification. Drawing on validated protocols and recent literature, it guides biomedical researchers in optimizing cancer and diabetes studies with this robust fluorescence-based platform.

• Z-WEHD-FMK: Optimizing Caspase Inhibition in Inflammation Re

  2026-06-24

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) delivers precise, irreversible inhibition of key inflammatory caspases, empowering mechanistically rigorous studies in pyroptosis, apoptosis, and infectious disease models. This article demystifies advanced workflows, comparative strengths, and troubleshooting strategies—anchored by breakthrough insights from recent HOXC8-caspase research.

• Angiotensin I for Cardiovascular and Antiviral Research

  2026-06-23

  Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) transforms cardiovascular and antiviral research by serving as a linchpin for dissecting the renin-angiotensin system and screening antihypertensive drugs. Recent evidence further links this peptide’s workflow to novel interfaces with viral pathogenesis, expanding its experimental reach.

• Trifluoperazine 2HCl: Beyond Dopamine D2 Inhibition in Immun

  2026-06-23

  Explore how Trifluoperazine 2HCl, a potent dopamine D2 receptor inhibitor, is revolutionizing immunological assays by modulating autophagy and ROS in macrophages. This article delivers unique insights into host-directed antibacterial strategies and advanced protocol considerations for research.

• Exo1 (SKU B6876): Data-Driven Exocytic Pathway Inhibition in

  2026-06-22

  This article addresses real-world challenges in membrane trafficking and exocytosis assays, demonstrating how Exo1 (SKU B6876) offers data-backed, reproducible solutions for cellular biology workflows. Readers will find scenario-driven guidance on experimental design, protocol optimization, and product selection, grounded in current research and practical lab experience.

• Macrophage Niche Dynamics and Kupffer Cell Plasticity in Liv

  2026-06-22

  This study demonstrates how inflammatory changes in the liver microenvironment drive the phenotypic and functional plasticity of Kupffer cells during metastasis. Through lineage tracing and functional assays, the authors reveal that liver metastasis–associated macrophages can be replenished by both monocyte-derived macrophages and the proliferation or infiltration of resident Kupffer cells, highlighting new therapeutic opportunities and complexities in targeting immunosuppressive myeloid populations.

• ALDH2 Activation Delays Heart Failure by Promoting Cardiomyo

  2026-06-21

  The reference study demonstrates that pharmacological activation of ALDH2 significantly extends the proliferative window of cardiomyocytes and delays pressure overload-induced heart failure in mice. These findings highlight ALDH2 as a promising target for cardiac regeneration and offer mechanistic insight into aldehyde detoxification in ischemic heart disease.

• Phosphorylation of NEP S-S-S Motif Regulates Influenza vRNP

  2026-06-20

  This study elucidates the critical role of NEP S-S-S motif phosphorylation in the nuclear export of influenza viral ribonucleoproteins (vRNPs). Through targeted mutagenesis and kinase inhibition, the authors demonstrate that phosphorylation at conserved serine residues is essential for efficient vRNP export, viral replication, and virulence, providing a mechanistic basis for novel antiviral targeting.

• PF-562271 HCl: Precision FAK/Pyk2 Inhibition in Cancer Model

  2026-06-19

  Explore how PF-562271 HCl, a potent FAK/Pyk2 inhibitor, enables unprecedented precision in dissecting tumor cell signaling and microenvironmental dynamics in cancer research. This article offers a deep dive into experimental design, protocol optimization, and translational considerations for leveraging PF-562271 HCl beyond conventional kinase studies.

• 2-(4,5,6,7-tetrabromo)acetic Acid: Small Molecule Inhibitor

  2026-06-19

  Leverage 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid as a precision small molecule inhibitor for dissecting kinase-driven protein interactions, phase separation, and phosphorylation. Explore advanced protocol enhancements, troubleshooting insights, and actionable experimental design recommendations for next-generation biochemical research.

449 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page